Caorui Lin
Impact in
-
- Extracellular vesicles in disease
- Muscle Physiology and Disorders
- RNA Interference and Gene Delivery
- Mitochondrial Function and Pathology
-
- Spinal Cord Injury Research
Papers in
- Epidemiology 11
- Hepatitis B Virus Studies 11
- Genetics 5
- Neurogenetic and Muscular Disorders Research 5
- Co-authors
- HaiFang Yin (12 shared papers)Ning Ran (7 shared papers)Xianjun Gao (5 shared papers)Mengyuan Geng (3 shared papers)Gang Han (9 shared papers)Xue Dong (1 shared paper)Junjin Li (1 shared paper)Qishui Ou (13 shared papers)
- Journals
- Molecular Therapy — Nucleic Acids (4 papers)Gut (2 papers)EMBO Molecular Medicine (2 papers)Biomaterials (2 papers)International Journal of Infectious Diseases (1 paper)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Caorui Lin
26 papers receiving 364 citations
Peers
Comparison fields: 5 of 57
- Molecular Biology 229
- Pathology and Forensic Medicine 36
- Genetics 18
- Aging 3
- Epidemiology 43
Countries citing papers authored by Caorui Lin
This map shows the geographic impact of Caorui Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caorui Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caorui Lin more than expected).
Fields of papers citing papers by Caorui Lin
This network shows the impact of papers produced by Caorui Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caorui Lin. The network helps show where Caorui Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Caorui Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 88 | |
| 2 | 2022 | 62 | |
| 3 | 2020 | 34 | |
| 4 | 2024 | 28 | |
| 5 | 2016 | 17 | |
| 6 | 2023 | 16 | |
| 7 | 2024 | 16 | |
| 8 | 2022 | 14 | |
| 9 | 2020 | 13 | |
| 10 | 2018 | 11 | |
| 11 | 2022 | 10 | |
| 12 | 2023 | 10 | |
| 13 | 2022 | 9 | |
| 14 | 2019 | 7 | |
| 15 | 2022 | 7 | |
| 16 | 2022 | 5 | |
| 17 | 2022 | 5 | |
| 18 | 2023 | 5 | |
| 19 | 2025 | 3 | |
| 20 | 2026 | 3 |
About Caorui Lin
Caorui Lin is a scholar working on Epidemiology, Genetics, Molecular Biology, Infectious Diseases and Biomaterials, having authored 27 papers that have together received 372 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (11 papers), Muscle Physiology and Disorders (10 papers), RNA Interference and Gene Delivery (7 papers), Neurogenetic and Muscular Disorders Research (5 papers), Extracellular vesicles in disease (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Gut microbiota and health (2 papers) and Mitochondrial Function and Pathology (1 paper). The work is most often cited by research in Molecular Biology (229 citations), Pathology and Forensic Medicine (36 citations), Genetics (18 citations), Aging (3 citations) and Epidemiology (43 citations). Caorui Lin has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include HaiFang Yin, Ning Ran, Xianjun Gao, Mengyuan Geng, Gang Han, Xue Dong, Junjin Li, Qishui Ou, Yiqi Seow and Tianbin Chen. Their work appears in journals such as Molecular Therapy — Nucleic Acids, Gut, EMBO Molecular Medicine, Biomaterials and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.